Balancing the risks and benefits of clinical trial.
This is a preview of subscription content, access via your institution
Relevant articles
Open Access articles citing this article.
-
Interaction kinetics of peptide lipids-mediated gene delivery
Journal of Nanobiotechnology Open Access 17 October 2020
-
High efficiency and long-term intracellular activity of an enzymatic nanofactory based on metal-organic frameworks
Nature Communications Open Access 12 December 2017
Access options
Subscribe to this journal
Receive 51 print issues and online access
$199.00 per year
only $3.90 per issue
Buy this article
- Purchase on Springer Link
- Instant access to full article PDF
Prices may be subject to local taxes which are calculated during checkout
References
Cavazzana-Calvo, M. et al. Science 288, 669–672 (2000).
Aiuti, A. et al. Science 296, 2410–2413 (2002).
Hacein-Bey-Abina, S. et al. Science 302, 415–419 (2003).
Fischer, A. Lancet 357, 1863–1869 (2001).
Antoine, C. et al. Lancet 361, 553–560 (2003).
Bonini, C. et al. Nature Med. 9, 367–369 (2003).
Dave, U. P., Jenkins, N. A. & Copeland, N. G., Science 303, 333 (2004).
Baum, C. et al. Blood 101, 2099–2114 (2003).
Williams, D. A. & Baum, C. Science 302, 400–401 (2003).
Acknowledgements
The authors report the shared opinion of the scientists and clinicians who developed and performed gene therapy of SCIDs in France, Italy and the United Kingdom, and in particular of Alessandro Aiuti, Claudio Bordignon, Alain Fischer, Salima Hacein-Bey-Abina and Maria Grazia Roncarolo.
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Cavazzana-Calvo, M., Thrasher, A. & Mavilio, F. The future of gene therapy. Nature 427, 779–781 (2004). https://doi.org/10.1038/427779a
Issue Date:
DOI: https://doi.org/10.1038/427779a